PepGen Inc.
PepGen Inc. (PEPG) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PEPG · as of Jun 9, 2026
Key Statistics
Explore PepGen Inc. Data
pepg stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 83.3%
The PEPG analyst consensus is Buy, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month price target is $5.50, representing +307.41% upside from the current price of $1.35.
Competitors & Peers
pepg competitorsPEPG
ALEC
APLT
CRBP
CRDF
CYBNStock Performance
Full HistoryAbout PepGen Inc.
PepGen Inc. is a clinical-stage biopharmaceutical company specializing in the development of oligonucleotide therapeutics designed to treat severe neuromuscular and neurological disorders. Its most ad…
what is pepgen inc. · pepg stock overview · pepgen inc. company profile · who is pepgen inc. ceo · pepg NASDAQ · pepgen inc. headquarters · pepgen inc. business segments
About Stock Overview & Key Data
PepGen Inc. (PEPG) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 6, 2022. As of the latest trading session, PEPG stock price is $1.35, with a market capitalization of $93.4M. The stock has returned -11.18% over the past 12 months and -79.26% year-to-date.
According to 6 Wall Street analysts, the consensus rating for PepGen Inc. stock is Buy, with an average 12-month price target of $5.50. In fiscal year 2025, PepGen Inc. reported revenue of — and net income of -$89.7M. For detailed data — including PepGen Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, PepGen Inc. (PEPG) stock price is $1.35. The stock is traded on NASDAQ under the ticker symbol PEPG. The 52-week range is $1.01 – $7.80.